HOUSE DOCKET, NO. 3104        FILED ON: 1/20/2023

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1085

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Jack Patrick Lewis

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act to address barriers to HIV prevention medication.

_______________

PETITION OF:

 

Name:

District/Address:

Date Added:

Jack Patrick Lewis

7th Middlesex

1/19/2023

James K. Hawkins

2nd Bristol

1/27/2023

Joanne M. Comerford

Hampshire, Franklin and Worcester

1/30/2023

Carol A. Doherty

3rd Bristol

1/31/2023

Susannah M. Whipps

2nd Franklin

1/31/2023

Lindsay N. Sabadosa

1st Hampshire

1/31/2023

Mindy Domb

3rd Hampshire

2/1/2023

David Paul Linsky

5th Middlesex

2/1/2023

Vanna Howard

17th Middlesex

2/3/2023

Sean Garballey

23rd Middlesex

2/8/2023

Kay Khan

11th Middlesex

2/8/2023

Colleen M. Garry

36th Middlesex

2/8/2023

Steven Ultrino

33rd Middlesex

2/8/2023

David Allen Robertson

19th Middlesex

2/8/2023

Tram T. Nguyen

18th Essex

2/8/2023

Christine P. Barber

34th Middlesex

2/9/2023

James C. Arena-DeRosa

8th Middlesex

2/9/2023

Michelle M. DuBois

10th Plymouth

2/13/2023

James Arciero

2nd Middlesex

2/16/2023

Shirley B. Arriaga

8th Hampden

2/22/2023

Simon Cataldo

14th Middlesex

2/23/2023

Rebecca L. Rausch

Norfolk, Worcester and Middlesex

2/23/2023

Natalie M. Higgins

4th Worcester

3/7/2023

Danielle W. Gregoire

4th Middlesex

3/10/2023

James B. Eldridge

Middlesex and Worcester

3/13/2023

Daniel Cahill

10th Essex

3/14/2023

Meghan Kilcoyne

12th Worcester

3/31/2023

Margaret R. Scarsdale

1st Middlesex

3/31/2023

Tommy Vitolo

15th Norfolk

4/4/2023

Adrian C. Madaro

1st Suffolk

4/5/2023

Danillo A. Sena

37th Middlesex

4/5/2023

David M. Rogers

24th Middlesex

4/10/2023

Julian Cyr

Cape and Islands

5/1/2023

Adam Scanlon

14th Bristol

5/17/2023

Judith A. Garcia

11th Suffolk

12/21/2023


HOUSE DOCKET, NO. 3104        FILED ON: 1/20/2023

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1085

By Representative Lewis of Framingham, a petition (accompanied by bill, House, No. 1085) of Jack Patrick Lewis and others for legislation to address barriers to HIV prevention medication healthcare coverage.  Financial Services.

 

The Commonwealth of Massachusetts

 

_______________

In the One Hundred and Ninety-Third General Court
(2023-2024)

_______________

 

An Act to address barriers to HIV prevention medication.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1: (a) As used in this section, the following words shall have the following meanings, unless the context clearly requires otherwise:-

“HIV”, human immunodeficiency virus.

“HIV prevention drug”, any preexposure prophylaxis drug approved for the prevention of HIV by the federal Food and Drug Administration, including any ancillary or support health service determined by the secretary of health and human services that is necessary to: (1) ensure that such a drug is prescribed or administered to a person who is not infected with HIV and has no medical contraindications to the use of such a drug; and (2) monitor such a person to ensure the safe and effective ongoing use of such a drug through: (A) an office visit; (B) laboratory testing; (C) testing for a sexually transmitted infection; (D) medication self-management and adherence counseling; (E) or any other health service specified as part of comprehensive HIV prevention drug services by the United States Department of Health and Human Services, the United States Centers for Disease Control and Prevention or the United States Preventive Services Task Force.

(b)(1) Notwithstanding any general or special law to the contrary, any policy, contract or certificate of health insurance subject to chapters 32A, 118E, 175, 176A, 176B, 176G, 176I, 176J or 176Q of the General Laws that provides coverage for any HIV prevention drug shall not require:

(A) any cost-sharing, including co-payments or co-insurance, or any deductible; and

(B) prior authorization, step therapy or any other protocol that could restrict or delay the dispensing or provision of any HIV prevention drug. 

(2) The commissioner of the division of insurance, in consultation with the secretary of health and human services, shall adopt any written policies, procedures or regulations necessary to implement this subsection.